NASDAQ:XRAY

DENTSPLY SIRONA Stock Forecast, Price & News

$64.67
-0.90 (-1.37 %)
(As of 06/14/2021 12:00 AM ET)
Add
Compare
Today's Range
$64.10
$65.60
50-Day Range
$63.85
$69.12
52-Week Range
$40.15
$69.54
Volume886,048 shs
Average Volume1.60 million shs
Market Capitalization$14.12 billion
P/E Ratio81.86
Dividend Yield0.61%
Beta0.93
30 days | 90 days | 365 days | Advanced Chart
Receive XRAY News and Ratings via Email

Sign-up to receive the latest news and ratings for DENTSPLY SIRONA and its competitors with MarketBeat's FREE daily newsletter.


DENTSPLY SIRONA logo

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc. designs, develops, manufactures, distributes, and sells various dental products and technologies primarily for professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression and restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers. The company also offers dental laboratory products, such as dental prosthetics that include artificial teeth, precious metal dental alloys, dental ceramics, and crown and bridge materials; and laboratory-based CAD/CAM milling systems, amalgamators, mixing machines, and porcelain furnaces. In addition, it provides dental technology products, including dental implants and related scanning equipment, and treatment software; orthodontic clear aligners and appliances for dental practitioners and specialist; and dental equipment, such as treatment centers, imaging equipment, dental handpieces, and computer aided design and machining systems for dental practitioners. Further, the company offers healthcare consumable products, such as urology catheters, medical drills, and other non-medical products. It markets and sells dental products through distributors, dealers, and importers; dental hygienists, assistants, laboratories, and schools; and urology products directly to patients, as well as through distributors to urologists, continence care nurses, general practitioners, and direct-to-patients. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1899 and is headquartered in Charlotte, North Carolina.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

Social Links


MarketRank

Overall MarketRank

1.64 out of 5 stars

Medical Sector

384th out of 2,100 stocks

Dental Equipment & Supplies Industry

3rd out of 8 stocks

Analyst Opinion: 1.2Community Rank: 2.4Dividend Strength: 1.7Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











DENTSPLY SIRONA (NASDAQ:XRAY) Frequently Asked Questions

Is DENTSPLY SIRONA a buy right now?

9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for DENTSPLY SIRONA in the last twelve months. There are currently 1 sell rating, 3 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" DENTSPLY SIRONA stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in XRAY, but not buy additional shares or sell existing shares.
View analyst ratings for DENTSPLY SIRONA
or view top-rated stocks.

What stocks does MarketBeat like better than DENTSPLY SIRONA?

Wall Street analysts have given DENTSPLY SIRONA a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but DENTSPLY SIRONA wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is DENTSPLY SIRONA's next earnings date?

DENTSPLY SIRONA is scheduled to release its next quarterly earnings announcement on Thursday, August 5th 2021.
View our earnings forecast for DENTSPLY SIRONA
.

How were DENTSPLY SIRONA's earnings last quarter?

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) issued its quarterly earnings results on Thursday, May, 6th. The medical instruments supplier reported $0.72 EPS for the quarter, topping the consensus estimate of $0.55 by $0.17. The medical instruments supplier earned $1.03 billion during the quarter, compared to the consensus estimate of $944.89 million. DENTSPLY SIRONA had a net margin of 4.99% and a trailing twelve-month return on equity of 9.45%. The company's revenue for the quarter was up 17.5% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.43 earnings per share.
View DENTSPLY SIRONA's earnings history
.

How has DENTSPLY SIRONA's stock been impacted by COVID-19?

DENTSPLY SIRONA's stock was trading at $42.56 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, XRAY stock has increased by 52.0% and is now trading at $64.67.
View which stocks have been most impacted by COVID-19
.

How often does DENTSPLY SIRONA pay dividends? What is the dividend yield for DENTSPLY SIRONA?

DENTSPLY SIRONA announced a quarterly dividend on Thursday, May 27th. Investors of record on Friday, June 25th will be paid a dividend of $0.11 per share on Friday, July 9th. This represents a $0.44 dividend on an annualized basis and a yield of 0.68%. The ex-dividend date of this dividend is Thursday, June 24th. This is an increase from DENTSPLY SIRONA's previous quarterly dividend of $0.10.
View DENTSPLY SIRONA's dividend history
.

Is DENTSPLY SIRONA a good dividend stock?

DENTSPLY SIRONA pays an annual dividend of $0.40 per share and currently has a dividend yield of 0.61%. DENTSPLY SIRONA does not yet have a strong track record of dividend growth. The dividend payout ratio of DENTSPLY SIRONA is 22.35%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, DENTSPLY SIRONA will have a dividend payout ratio of 12.66% next year. This indicates that DENTSPLY SIRONA will be able to sustain or increase its dividend.
View DENTSPLY SIRONA's dividend history.

What guidance has DENTSPLY SIRONA issued on next quarter's earnings?

DENTSPLY SIRONA issued an update on its FY 2021 earnings guidance on Thursday, May, 27th. The company provided earnings per share (EPS) guidance of 2.750-2.900 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.730. The company issued revenue guidance of $4.10 billion-$4.30 billion, compared to the consensus revenue estimate of $4.14 billion.

What price target have analysts set for XRAY?

9 equities research analysts have issued 12-month price targets for DENTSPLY SIRONA's shares. Their forecasts range from $47.00 to $78.00. On average, they expect DENTSPLY SIRONA's share price to reach $64.00 in the next year. This suggests that the stock has a possible downside of 1.0%.
View analysts' price targets for DENTSPLY SIRONA
or view top-rated stocks among Wall Street analysts.

Who are DENTSPLY SIRONA's key executives?

DENTSPLY SIRONA's management team includes the following people:
  • Mr. Donald M. Casey Jr., CEO & Director (Age 61, Pay $1.63M) (LinkedIn Profile)
  • Mr. Jorge M. Gomez, Exec. VP & CFO (Age 53, Pay $1.42M)
  • Mr. Keith John Ebling, Exec. VP, Gen. Counsel & Sec. (Age 52, Pay $1.06M)
  • Ms. Lisa M. Yankie, Sr. VP and Chief HR Officer & Communications (Age 52, Pay $606.51k)
  • Mr. Walter Petersohn, Sr. VP & Chief Commercial Officer (Age 54, Pay $904.22k)
  • Mr. Ranjit S. Chadha, Chief Accounting Officer (Age 51)
  • Mr. Cord Friedrich Staehler, Sr. VP of Digital Platforms & Solutions and CTO (Age 51)
  • Mr. John Sweeney C.F.A., CFA, VP of Investor Relations
  • Mr. Chidam Alagappa Chidambaram, Sr. VP, Chief Marketing Officer & Chief Digital Officer (Age 54)
  • Dr. Albert J. Sterkenburg, Sr. VP (Age 57)

What is Don Casey's approval rating as DENTSPLY SIRONA's CEO?

105 employees have rated DENTSPLY SIRONA CEO Don Casey on Glassdoor.com. Don Casey has an approval rating of 70% among DENTSPLY SIRONA's employees.

Who are some of DENTSPLY SIRONA's key competitors?

What other stocks do shareholders of DENTSPLY SIRONA own?

Based on aggregate information from My MarketBeat watchlists, some companies that other DENTSPLY SIRONA investors own include NVIDIA (NVDA), Intel (INTC), QUALCOMM (QCOM), The Boeing (BA), General Electric (GE), International Business Machines (IBM), Broadcom (AVGO), Comcast (CMCSA), Gilead Sciences (GILD) and Tesla (TSLA).

What is DENTSPLY SIRONA's stock symbol?

DENTSPLY SIRONA trades on the NASDAQ under the ticker symbol "XRAY."

Who are DENTSPLY SIRONA's major shareholders?

DENTSPLY SIRONA's stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (7.83%), Price T Rowe Associates Inc. MD (7.24%), Artisan Partners Limited Partnership (6.83%), Generation Investment Management LLP (6.53%), Janus Henderson Group PLC (4.78%) and First Eagle Investment Management LLC (3.11%). Company insiders that own DENTSPLY SIRONA stock include Eric Brandt, Gregory T Lucier, Michael C Alfano, Walter Petersohn, William E Newell and Willie A Deese.
View institutional ownership trends for DENTSPLY SIRONA
.

Which major investors are selling DENTSPLY SIRONA stock?

XRAY stock was sold by a variety of institutional investors in the last quarter, including Generation Investment Management LLP, Nuance Investments LLC, Schroder Investment Management Group, Artisan Partners Limited Partnership, First Eagle Investment Management LLC, New York State Common Retirement Fund, Boston Trust Walden Corp, and Pragma Gestao DE Patrimonio Ltd.. Company insiders that have sold DENTSPLY SIRONA company stock in the last year include Eric Brandt, Walter Petersohn, and Willie A Deese.
View insider buying and selling activity for DENTSPLY SIRONA
or view top insider-selling stocks.

Which major investors are buying DENTSPLY SIRONA stock?

XRAY stock was acquired by a variety of institutional investors in the last quarter, including Price T Rowe Associates Inc. MD, Janus Henderson Group PLC, BlackRock Inc., TimesSquare Capital Management LLC, Holocene Advisors LP, Ameriprise Financial Inc., Bank of New York Mellon Corp, and Renaissance Technologies LLC.
View insider buying and selling activity for DENTSPLY SIRONA
or or view top insider-buying stocks.

How do I buy shares of DENTSPLY SIRONA?

Shares of XRAY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is DENTSPLY SIRONA's stock price today?

One share of XRAY stock can currently be purchased for approximately $64.67.

How much money does DENTSPLY SIRONA make?

DENTSPLY SIRONA has a market capitalization of $14.12 billion and generates $3.34 billion in revenue each year. The medical instruments supplier earns $-83,000,000.00 in net income (profit) each year or $1.79 on an earnings per share basis.

How many employees does DENTSPLY SIRONA have?

DENTSPLY SIRONA employs 15,200 workers across the globe.

When was DENTSPLY SIRONA founded?

DENTSPLY SIRONA was founded in 2016.

What is DENTSPLY SIRONA's official website?

The official website for DENTSPLY SIRONA is www.dentsplysirona.com.

Where are DENTSPLY SIRONA's headquarters?

DENTSPLY SIRONA is headquartered at 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC, 28277.

How can I contact DENTSPLY SIRONA?

DENTSPLY SIRONA's mailing address is 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC, 28277. The medical instruments supplier can be reached via phone at 844-546-3722 or via email at [email protected]


This page was last updated on 6/15/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.